FB-TW

Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts

Wednesday, August 16, 2017

Why I won’t take statins for my high cholesterol - Julianne



In Summary, for those who took the statin for 5 years (with known heart disease):

Benefits in NNT
  • 1 in 83 were helped (life saved)
  • 1 in 39 were helped (preventing non-fatal heart attack)
  • 1 in 125 were helped (preventing stroke)
Harms in NNH
  • 1 in 100 were harmed (develop diabetes*)
  • 1 in 10 were harmed (muscle damage)


If you have had a heart attack and change your diet to a Mediterranean diet – you will get far more benefit than Statin drugs:

In Summary, for those who adhered to the Mediterranean diet:

Benefits in NNT
  • 1 in 18 were helped (preventing repeat heart attack)
  • 1 in 30 were helped (preventing death)
  • 1 in 30 were helped (preventing cancer)
Harms in NNH
  • None were harmed
 
 
And if you want to prevent heart disease the Mediterranean diet is also far more effective than statin drugs:
 
In Summary, for those who ate the Mediterranean diet:

Benefits in NNT
  • 1 in 61 were helped (avoiding a stroke, heart attack, or death)
Harms in NNH
  • None were harmed (diet effects)

Read the full article here.


Friday, October 3, 2014

The Cholesterol Myths - Ravnskov

        
. . . that cholesterol is not a deadly poison, but a substance vital to the cells of all mammals? 
               
. . . that your body produces three to four times more cholesterol than you eat? 
                
. . . that this production increases when you eat only small amounts of cholesterol and decreases when you eat large amounts? 
                
. . . that the  “prudent” diet, low in saturated fat and cholesterol, cannot lower your cholesterol more than a small percentage? 
                
. . . that the only effective way to lower cholesterol is with drugs? 
                
. . . that the cholesterol-lowering drugs are dangerous to your health and may shorten your life?
                 
. . . that the cholesterol-lowering drugs, called statins, do lower heart-disease mortality a little, but this is because of effects other than cholesterol lowering? Unfortunately, they also stimulate cancer. 
                
…that you may become aggressive or suicidal if you lower your cholesterol too much? 
                
…that polyunsaturated fatty acids, those which are claimed to prevent heart attacks, stimulate infections and cancer in rats? 
                
…that if you eat too much polyunsaturated oil you will age faster than normal? You will see this on the outside as wrinkled skin. You can’t see the effects of premature aging on the inside of your body, but you will certainly feel them. 
                
…that people whose blood cholesterol is low  become just as atherosclerotic as people whose cholesterol is high? 
        
…that more than thirty studies of more than 150,000 individuals have shown that people who have had a heart attack haven’t eaten more saturated fat or less polyunsaturated oil than other people? 
                
…that old people with high cholesterol live longer than old people with low cholesterol? 
                
…that high cholesterol protects against infections? 
                
…that many of these facts have been presented in scientific journals and books for decades but proponents of the diet-heart hypothesis never tell them to the public? 
                
…that the diet-heart idea and the cholesterol campaign create immense prosperity for researchers, doctors, drug producers and the food industry?





"Dr. Ravnskovs contention is that the diet-heart idea is built on sand. He leads us through the history of the concept in an interesting and readable way. His writing clearly demonstrates the enormous depth and range of his reading on this subject. Step by step he examines the evidence for the diet-heart idea, and step by step he shows us how that evidence may be flawed and contradicted by other research that is rarely acknowledged and quoted."

 ~ Michael Gurr, PhD

Terrific response to Uffe Ravnskov's offer to view “The Cholesterol Myths” at 
======================================================================
Read the complete article here.

Monday, July 21, 2014

Do statins prevent or promote cancer? - Current Oncology

Do statins prevent or promote cancer?

Mark R. Goldstein MD FACP, Medical Director, Fountain Medical Court, 9410 Fountain Medical Court, Suite
The Editor, Current Oncology December 24, 2007
 
In their commentary, Drs. Takahashi and Nishibori discuss putative antitumour effects of statins. However, prospective data suggest that statins actually increase cancer in certain segments of the population. Additionally, new findings regarding the immunomodulatory effects of statins may explain the mechanism by which that increase occurs.

Statins increase the number of regulatory T cells (Tregs) in vivo by inducing the transcription factor forkhead box P3. Although that increase may be beneficial in stabilizing atherosclerotic plaque by reducing the effector T-cell response within the atheroma, it might impair both the innate and adaptive host antitumour immune responses. Not surprisingly, the number of Tregs present in many solid tumours correlate inversely with patient survival.

Indeed, analysis of large randomized statin trials demonstrate a highly significant (p = 0.009) inverse association between achieved low-density lipoprotein cholesterol levels and cancer. Close inspection of statin trials reveal the specific populations at risk for the development of incident cancer with statin treatment. These include the elderly and people with a history of breast or prostate cancer,. Furthermore, statin-treated individuals undergoing immunotherapy for cancer may be at increased risk for worsening cancer.

The elderly are relatively immunosuppressed and are more likely to harbour occult cancers. In the prosper (Prospective Study of Pravastatin in the Elderly at Risk) trial, a 3.2-year prospective study of pravastatin for cardiovascular disease prevention in the elderly (mean age at trial entry: 75 years) at high risk for cardiovascular disease, cancer incidence was significantly increased in subjects randomized to pravastatin. In fact, the increase in cancer mortality equalled in magnitude the decrease in cardiovascular disease mortality in the statin-treated patients, leaving all-cause mortality unchanged. Likewise, post hoc analysis of the lipid study, a 6-year prospective trial of pravastatin in individuals with cardiovascular disease, revealed a significant increase in cancer incidence in the elderly subjects (age: 65–75 years) randomized to pravastatin. In a secondary analysis of the tnt (Treating to New Targets) study, elderly subjects randomized to high-dose atorvastatin (80 mg daily) versus low-dose atorvastatin (10 mg daily) demonstrated a trend toward increased death, largely from an increase in cancer mortality. Therefore, the increase in incident cancer in the elderly might be dose-related. It is highly plausible that the elderly are particularly sensitive to a statin-induced increase in Tregs, further impairing their immune response to cancer.

An alarming increase in breast cancer incidence, some of which were recurrences, was seen in women randomized to pravastatin in the care trial Thereafter, cancer was an exclusion criterion in randomized statin trials. In clinical practice, however, it is not infrequent to find an association between recurrence of breast cancer and concurrent statin therapy. Long-term follow-up (10 years after trial completion) of woscops (West of Scotland Coronary Prevention Study), a 5-year prospective trial of pravastatin in hypercholesterolemic men, revealed an increase in prostate cancer in the men who were randomized to pravastatin therapy. That finding indicates that cancers may become evident a decade or more after treatment with statins. Treg increases have been associated with both breast and prostate cancers,, and therefore, it is highly plausible that the increase in cancers seen with statin therapy is related to a statin-induced increase in Tregs.

Statin therapy has been associated with tumour progression leading to radical cystectomy in patients treated for bladder cancer with bacille Calmette–Guérin immunotherapy. That association may be likewise due to a statin-induced increase in Tregs, resulting in impaired host antitumour immunity.
Statin trials have typically randomized subjects free of prevalent cancers and have been about 5 years in duration. Long-term follow-up data are limited, particularly for the development of cancer. Statins are now promoted for widespread use in adults of all ages and at high doses, potentially for decades. Importantly, they are used in individuals with other significant comorbidities such as cancer. Unfortunately, the post-market surveillance of drugs has been poor. Because cancer is highly prevalent in the population, particularly in the elderly, a statin-induced increase in cancer incidence will likely go unrecognized.

Long-term prospective data are needed on the feasibility of statin therapy in the very elderly, the immuno-suppressed, and those with prevalent cancer. Furthermore, long-term outcome data are needed in young individuals treated with statins for prolonged time periods. Perhaps a constant increase in Tregs over years, even in the young, will weaken host antitumour immune surveillance and increase the risk for various cancers.

In conclusion, we feel that there is ample evidence that statins may promote cancer in certain segments of the population. Currently, the indications for statin therapy are based on lipoprotein levels, prevalent cardiovascular disease, other vascular risk factors, and family history. Maybe it is time for a new paradigm that also includes age extremes, prevalent cancer, a past history of cancer, and overall immunocompetence.

REFERENCES

1. Takahashi HK, Nishibori M. The antitumour activities of statins. Curr Oncol. 2007;14:246–7. [PMC free article] [PubMed]
2. Mausner–Fainberg K, Luboshits G, Mor A, et al. The effect of hmg-coa reductase inhibitors on naturally occurring cd4+cd25+ T cells. Atherosclerosis. 2007 [Epub ahead of print] [PubMed]
3. Goronzy JJ, Weyand CM. Immunosuppression in atherosclerosis: mobilizing the opposition within. Circulation. 2006;114:1901–4. [PubMed]
4. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. cd4+cd25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A. 2007;104:19446–51. [PMC free article] [PubMed]
5. Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest. 2007;117:1167–74. [PMC free article] [PubMed]
6. Yakirevich E, Resnick MB. Regulatory T lymphocytes: pivotal components of the host antitumor response. J Clin Oncol. 2007;25:2506–8. [PubMed]
7. Alsheikh–Ali AA, Maddukuri PV, Han H, Karas RH. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol. 2007;50:409–18. [PubMed]
8. Shepherd J, Blauw GJ, Murphy MB, et al. on behalf of the prosper (Prospective Study of Pravastatin in the Elderly at Risk) study group. Pravastatin in elderly individuals at risk of vascular disease (prosper): a randomised controlled trial. Lancet. 2002;360:1623–30. [PubMed]
9. Hunt D, Young P, Simes J, et al. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the lipid trial. Ann Intern Med. 2001;134:931–40. [PubMed]
10. Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK. on behalf of the Treating to New Targets Study Steering Committee and Investigators. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med. 2007;147:1–9. [PubMed]
11. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001–9. [PubMed]
12. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM. on behalf of the West of Scotland Coronary Prevention Study Group. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357:1477–86. [PubMed]
13. Hoffmann P, Roumeguère T, Schulman C, van Velthoven R. Use of statins and outcome of bcg treatment for bladder cancer. N Engl J Med. 2006;355:2705–7. [PubMed]
14. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211:144–56. [PMC free article] [PubMed]
15. Winer EP, Harris JR, Smith BL, D’Alessandro HA, Brachtel EF. Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer. N Engl J Med. 2007;357:1640–8. [PubMed]
==========================================================================
Read the complete article here.

Tuesday, February 18, 2014

Low Cholesterol’s Cancer Link Illustrates Innate Intelligence - Campos

Low Cholesterol’s Cancer Link Illustrates Innate Intelligence

Dr. Nick Campos
 

Oh boy, here we go…so you know that I’m not shy about discussing my health. I’ve got nothing to hide, and I approach my health from a very proactive position. I also have a belief system that is integral to how I care for my health—I know that one day I am going to die, could be tomorrow, but for me to experience my life to the fullest today, I am quite certain that it requires me to care for my body as one of my most valuable assets. So I don’t obsess about “never getting sick,” I just treat my body like I love it, and I trust that it knows—through its innate intelligence–how to run my body, provided I treat it in the right ways. Simple.

So long-time readers of this blog will recall that I have high cholesterol. Have I ever been worried about it? No, never. Not even a little. In fact, I just had my annual physical in February. Once again, stellar health, thank you, thank you…athlete’s numbers…’cept I have high cholesterol.

If you’ve been following my story, you’ll recall that my doc (love him, bless his heart…and I mean that sincerely; he is the greatest) has, of course, recommended I go on statins. Now I’ve got my inner theories about it, regarding liability and stuff like that, but whatever…he knows I’m not going to take them. It’s simple: my HDL levels (“good” cholesterol) are above and beyond excellent. My total cholesterol to HDL ratio is at the “optimum” level. Ha ha ha…I’m in the absolute lowest risk category for heart disease: I’m not taking statins!

And my doctor knows this. I saw the perplexed look on his face when I pointed out those values to him (I guess that’s not the typical presentation of his high cholesterol patients). Shrugging it off, he still recommended the statins (and has every year for the last four). Sigh

Okay, here’s the point of this piece: A recent study has shown that low levels of LDL (“bad”) cholesterol, in the absence of cholesterol lowering medications, has a strong link to cancer. What?! That’s right, and although we’ve known of this link for a long time (30+ years), this study was the first ever look at the low LDL-cancer link over an extended period of time (~19 years), and only in patients with no history of taking cholesterol-lowering drugs.

The results showed a couple things. One, the link cannot be due to taking statins since all subjects were statin-free throughout the study, and two, low cholesterol cannot be a byproduct of the cancer itself, since low LDL levels were observed well before any preclinical signs of cancer were present. In other words, statins don’t cause cancer, and cancer doesn’t cause low cholesterol. That we know.

What we don’t know is what the connection is. Hmmm…. Well let me give it a try: I believe that the body has an internal wisdom, an Innate Intelligence, that directs its operation. I believe this system is flawless. The body knows what to do at all times, and provided with the right fuel (whole, natural foods), necessary movement, proper bodywork and tension relief, adequate rest, adequate hydration, full, deep abdominal breath and minimal toxins, it will continue to operate flawlessly until it expires (which it will also do flawlessly).

However, too many people do not observe the natural laws of health—they eat poorly, fail to exercise regularly, ignore bodywork until they are in so much pain they can’t stand it, get little rest, drink too many sodas and not enough water, breathe shallowly from their chest, and take multiple drugs and other toxins, and so, yeah…their Innate Intelligence get severely challenged and fatigued; or it can only do the minimum with the resources it is given and becomes overloaded.

Further, we have a medical science that believes its own limited observations are the whole to the puzzle, and it make erroneous conclusions based on this small, piece-wise information, and yet it still believes it knows how to run the body better than Mother Nature does. And then we find out later that there is, in fact, more to the puzzle. You don’t say…?

But taking all the above points into consideration: Somehow when LDL cholesterol is disrupted from one of its many functions—that is, when it’s in too low of concentration—leads to cell overgrowth or cancer. Thus, not that statins, by lowering cholesterol, will cause cancer, but instead, perhaps this medical campaign to reduce cholesterol at all costs is an erroneous one. Perhaps the body produces what it needs (cholesterol can be both endogenous [created within] and exogenous [recieved from without]), and putting everybody on statins, particularly those with stellar numbers in all other health measurements, is just plain foolish.

No medical doctor or pharmaceutical researcher will ever know human physiology better than the human body does. Why the arrogant medical scientific (?) machine believes that it understands what cholesterol levels should be better than the body does is completely perplexing to me. If we were simply talking about a few hundred thousand people on statins because they have super-dangerously high levels that puts them at severe risk of heart disease, then…okay, I would understand. But to have tens of millions of Americans on these useless and dangerous cholesterol lowering drugs is purely idiotic.

So once again I have to believe it all comes down to three things–money (pharmaceuticals), liability (doctors protecting their asses) and job protection (medical professionals making sure they do not become obsolete). That’s the reality behind the cholesterol-statin push in the western world. I’m sure that’s why my doctor recommends statins to me despite my excellent health, I’m sure it’s why statins are called “the best selling drugs of all time,” and I’m sure it will continue until the next blockbuster drug addressing normal physiology comes along to take it’s place. Shouldn’t be too far off—stay tuned.
==============================================================
Read the complete article here.

Wednesday, February 12, 2014

Statins for the primary prevention of cardiovascular disease - BMJ

Statins for the primary prevention of cardiovascular disease


"The reason why statin treatment may result in cancer is probably not an effect of the drug, but that low cholesterol predisposes to cancer. Thus, nine cohort studies including more than 140 000 individuals found that cancer was inversely associated with cholesterol measured 10–30 years earlier, and the association persisted after exclusion of cancer cases appearing during the first 4 year."

====================================================================
Read the complete article here.

Sunday, May 5, 2013

Fears of cancer link to statin - AB Rossebo,

Scientists raise fears of cancer link to statin used by thousands


 
This post includes a synopsis of a study published in the New England Journal of Medicine September 25, 2008; 359(13): 1343-56 and a recipe for roccoli, bacon and nut salad.

Study title and authors:

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
AB Rossebo, TR Pedersen, K Boman, P Brudi, JB Chambers, K Egstrup, E Gerdts, C Gohlke-Barwolf, I Holme, YA Kesaniemi, W Malbecq, CA Nienaber, S Ray, T Skjaerpe, K Wachtell, R Willenheimer, and SEAS Investigators Division of Cardiology, Aker University Hospital, Trondheimsveien 235, N-0514 Oslo, Norway.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/18765433

This trial observed the effects of the drug Inegy (a combination of simvastatin and ezetimibe).The trial was a randomizsd, double-blind trial involving 1,873 patients with mild-to-moderate, asymptomatic aortic stenosis (obstruction of blood flow across the aortic valve). The patients received either 40 mg of simvastatin plus 10 mg of ezetimibe or placebo daily and were followed for 52 months.

The study found:

(a) Those taking the simvastatin/ezetimibe combination had a 4% increased risk of death compared to those taking placebo.

(b) Those taking the simvastatin/ezetimibe combination had a 21% increased risk of death from heart failure compared to those taking placebo.

(c) Those taking the simvastatin/ezetimibe combination had a 67% increased risk of death from cancer compared to those taking placebo.

(d) Those taking the simvastatin/ezetimibe combination had a 195% increased risk of death from violence or accidents compared to those taking placebo.


Professor Heinz Drexel, of the University of Innsbruck in Austria and spokesman for the European Society of Cardiology, said: "I am not sure that the efficacy is proven and I am not sure that the safety is proven. I wouldn't take the drug myself".

In Britain, about 300,000 NHS prescriptions have been dispensed for Inegy in the last two years.
==================================================================
Read the complete article here.

Monday, April 8, 2013

Does Red Meat Cause Inflammation? - Kresser

 
By on April 5, 2013  
steak
So far in my series on red meat, I’ve discussed why red meat is good for you and why grass fed is a better choice than grain fed. We now know that red meat is a healthy choice, due to its high nutritive value and superior fatty acid profile among other reasons. In the comments on these posts, however, I’ve noticed a few readers have mentioned other components in red meat that are concerning, due to evidence for the potential for inflammation or carcinogenesis.

Yet is this evidence strong enough to advise a reduction in red meat, or is this yet another false alarm creating unnecessary fear of eating meat?
Red meat and inflammation: another myth bites the dust.
Two different controlled trials have measured inflammation markers in response to increased red meat intake, and both have found that red meat does not elevate these markers. The first study concludes that increasing red meat consumption by replacing carbohydrates in the diet of non-anemic individuals actually reduces markers of inflammation. (1) The other study showed that in anemic women, inflammation markers on a diet high in red meat were not significantly different from those on a diet high in oily fish. (2) This evidence suggests that red meat is not more inflammatory than other meats for most people, and is potentially less inflammatory than dietary carbohydrates.

However, I’d like to discuss a couple of other specific mechanisms that are often blamed for inflammation.

Neu5Gc

Despite the lack of controlled trials demonstrating that red meat is inflammatory, there has been recent concern over a compound in red meat called Neu5Gc. (3) Neu5Gc is a monosaccharide that acts as a type of signaling molecule in mammalian cells, and one of its functions is to help the immune system distinguish between ‘self’ cells and ‘foreign’ cells. (4) Humans lost the ability to produce Neu5Gc millions of years ago through a genetic mutation, although we still produce the closely related compound Neu5Ac. (5) Humans are unique in this respect, because most other mammals still produce Neu5Gc, which is why that compound is found in mammalian meat.

When humans consume red meat and milk products, we incorporate some of this compound into our own tissues, especially tissues that grow at a fast pace such as fetuses, epithelial and endothelial tissue, and tumors. (6) The concern is that most of us also have anti-Neu5Gc antibodies circulating in our blood, and some researchers have suggested that these antibodies react with the Neu5Gc in our tissues to create chronic inflammation, leading to chronic diseases such as cancer.

The problem is that researchers are nowhere near proving that hypothesis. Research is in the very earliest stages, and while some fascinating hypotheses involving this molecule are being generated, the studies needed to confirm or refute these hypotheses are nonexistent. Most of the studies done on the topic acknowledge that at this point, any role in chronic inflammation is speculative, but many who have cited their research neglect to acknowledge that limitation. Thus begins a new round of fear mongering at the expense of red meat.

In the absence of conclusive evidence one way or another, it can be helpful to remember that red meat has been part of the human diet for much of our history, and remains an important dietary element of many healthy cultures. For example, the traditional diet of the Masai was composed almost entirely of red meat, blood, and milk – all high in Neu5Gc – yet they were free from modern inflammatory diseases. (7) If Neu5Gc really caused significant inflammation, the Masai should’ve been the first to know, because they probably couldn’t have designed a diet higher in Neu5Gc if they tried.

Arachidonic Acid

Arachidonic acid (AA) is often cited as a source of inflammation, and because AA is found primarily in eggs and meat, this concern could contribute to the view that red meat is inflammatory. AA is an essential omega-6 fatty acid that is a vital component of cell membranes and plays an important role in the inflammatory response. (8) It’s especially necessary during periods of bodily growth or repair, and is thus a natural and important component of breast milk. (9) AA is sometimes portrayed as something to be avoided entirely simply because it is ‘inflammatory,’ but as usual, that view drastically oversimplifies what actually happens in the body.

It’s true that AA plays a role in inflammation, but that’s a good thing! It ensures that our body responds properly to a physical insult or pathogen, and it also helps ensure that the inflammatory response is turned off when it’s no longer needed. AA interacts with other omega-3 and omega-6 fatty acids in intricate and subtle ways, and an imbalance in any of those fats has undesirable effects. For example, low doses of EPA tend to increase tissue levels of AA, while high doses decrease levels of AA, which probably explains why the benefits of fish oil supplementation are lost at higher doses. (10) In epidemiological studies, higher plasma levels of both AA and the long-chain omega-3 PUFA were associated with the lowest levels of inflammatory markers. (11, 12) And clinical studies have found that adding up to 1,200 mg of AA per day—which is 12 times higher than the average intake of AA in the U.S.— to the diet has no discernible effect on the production of inflammatory cytokines. (13, 14) What’s more, our Paleolithic ancestors (who were largely free of chronic, inflammatory disease) consumed at least twice the amount of AA that the average American does today. (15)
Finally, it’s important to note that red meat actually has a lower concentration of AA than other meats because of its lower overall PUFA content. (16)(17) Additionally, red meat has been shown to increase tissue concentrations of both AA and the long chain omega-3s DHA and EPA, preserving the all-important balance of omega-3 and omega-6. (18)

Charred meat and cancer

The final concern I want to address involves compounds that are produced when meat is cooked, including advanced glycation end products (AGEs), heterocyclic amines (HAs), and polycyclic aromatic hydrocarbons (PAHs). Again, this applies to all meat, not just red meat, but it can still contribute to the perception that red meat is unhealthy.

HAs and PAHs have both been shown to cause cancer in animal models, and although these results can’t necessarily be extrapolated to humans, it’s probably wise to limit exposure to these two compounds. (19)(20) HAs and PAHs are formed when meat is cooked using high-heat or dry cooking methods such as frying, grilling, or smoking. But while cooked meat is the only significant source of HAs, PAHs are a ubiquitous environmental contaminant, and the bulk of dietary PAHs actually come from vegetables and grains. (21) In fact, levels of PAH in leafy vegetables are comparable to levels in smoked meat! However, the highest food levels of PAH are found in charred meats that have been cooked over an open flame.

AGEs are different from the other compounds in that they can be formed both endogenously and exogenously. (22) Like HAs and PAHs, AGEs are formed when foods – particularly meat – are cooked, although they are also naturally present even in uncooked meat. However, dietary AGEs do not tell the whole story, because they can also form through various metabolic pathways in the body.

One study showed that while omnivores generally have higher dietary intakes of AGEs than vegetarians, vegetarians actually end up with higher concentrations of AGEs in their plasma. (23) The authors hypothesized that their results were due to the increased fructose intake of vegetarians, although another plausible mechanism appears to be the inhibition of AGE formation by carnosine, an amino acid found in meat. (24)(25) Either way, I wouldn’t be terribly concerned about AGEs in meat, although I still recommend favoring lower-heat cooking methods to avoid HAs and PAHs.

If you do want to grill or fry your meats, you can significantly reduce the formation of all of these compounds by using an acidic marinade, which has the added bonus of tasting great! Marinating beef for one hour reduced AGE formation by over half, and marinades can cut HA formation in meat by up to 90%. (26)

Overall, there’s no good evidence that red meat is more inflammatory than other meats, and some evidence indicating that it’s less inflammatory. Just like any other food, it’s certainly possible for people to have individual intolerances to red meat that might induce inflammation, but there’s no reason for most people to restrict red meat on the basis of inflammation. Additionally, AGEs from meat are probably not a concern, and meat eaters might even be better off when it comes to plasma levels of AGEs. Any concerns about other compounds produced by cooking meat can be minimized simply by favoring wet or low-heat cooking methods, or using a marinade when high-heat methods are desired.

I hope I’ve addressed all the remaining health concerns with eating red meat, but I’d like to hear your thoughts in the comments below.
===============================================================
Read the complete article here.
Also read more here.

Tuesday, March 26, 2013

Should Women take Statin Drugs – ever? - Watson

http://dietheartnews.com/2012/11/should-women-ever-take-statin-drugs/

Should Women take Statin Drugs – ever?

| November 27, 2012 |
 
A true story…
In 1987, Mevacor, the first statin cholesterol-lowering drug, was introduced in record short time. Within a decade, Zocor, Pravachol, Lescol, Lipitor and Baycol were added. In August 2001, after 31 deaths from a muscle-destroying side effect, Bayer of Germany withdrew Baycol.

While clinical studies have demonstrated a small benefit among people with active, late stage heart disease, the threat of muscle-destroying side effects, liver damage and cancer are on the rise.

As reported in the Felix Letter, in the “supposedly successful” Simvastatin trial (Zocor), where the average life extension in the treatment group after 5 years was 24 days, Dr. Louis Krut is quoted as saying:

“If we were to set a very modest goal to extend their average life by only 1 year, it would require them to take simvastatin for 83 years.”
 
According to Dr. Uffe Ravnskov, statin drugs may stimulate cancer. Because the latency period between exposure and incidence is as long as 20 years, we do not know the extent to which the statin drugs will increase the rate of cancer in coming decades.

In the CARE study (Pravachol), 12 women in the treatment group developed breast cancer compared to just one in the control group (not taking the drug). And blood levels in the patients taking statin drugs were close to those that cause cancer in rodents.

Why take a chance with muscle-destroying side effects, liver failure and cancer? That’s what I asked my now deceased mother-in-law several years ago when she started taking Zocor.

Doris’s total cholesterol was 285. She was a little overweight but, at age 72, she was enjoying life and had no history of chronic illness. She drove a car, went shopping, and was even looking for a boyfriend!

As she lay in ICU one year later with elevated liver enzymes and a serious blood infection, her doctor took her off of Zocor. Once she stabilized, suspecting the drug had caused harm, we asked her doctor to recheck her cholesterol.

Yes – Doris was dying, but why not see if the drug treatment nonetheless had succeeded in lowering her cholesterol. When the doctor reluctantly complied – it took a letter from the family – Doris’s cholesterol was 130 – a drop of 155 mg/dl in less than a year.

After a few more agonizing hospitalizations, Doris was dead – Zocored within a year of starting the drug. Her doctor said she died of leukemia. Women – don’t let this happen to you. There are no circumstances – ever – when a woman should take a drug to lower cholesterol.

Women with higher cholesterol – live longer. Also, you must ask your doctor for a complete lipid evaluation. Just focusing on total cholesterol is a serious medical mistake. The ultimate price you may pay is an agonizingly slow death from cancer, liver failure or leukemia.
===========================================================
Read the complete article here.

Thursday, March 7, 2013

Observational studies - Eades

Observational studies or CORRELATION IS NOT CAUSATION

observational study blog Observational studies
One view of the value of epidemiology
A day almost never passes without someone sending a comment my way about some recent study, plucked by the media from the hundreds published that same day, showing that low-carb diets cause brain fog or decreased longevity or cancer of some type or any number of conditions any of us would rather not have. These comments always end with the plaintive request, is there any truth to this?
My answer follows: This data comes from an observational study, and, as such, can’t possibly indicate causality.

Since I get these comments so often and answer them the same equally often, I figured it was about time to write a post on what an observational study really is so that I can link to it when I give my standard reply.

I can then add this post to the ones on the glycemic index and relative risk, both of which serve the same purpose. I can simply link instead of explaining what these terms mean each time I have to use them.

Observational studies – also called prospective or cohort studies and sometimes even epidemiological studies – are the kind most often reported in the media simply because there are so many of them. These are the studies in which researchers look for disease disparities between large populations of people with different diets, lifestyles, medications, incomes, etc. If disease disparities are found to exist between groups, then researchers try to make the case that the difference in diet, lifestyle, medication, etc. is the driving force behind the disparity.

We’ve all seen these studies by the score. We read that a large study population of people is separated into two groups based on blood levels of vitamin C. One group of subjects has high blood levels, the other group has lower blood levels. And since every one seems to believe that vitamin C protects against the common cold, the researchers decide to monitor these two groups for a year and find that the group with the highest blood levels of vitamin C has the fewest colds. These findings are rushed into publication, and soon we read everywhere that vitamin C prevents the common cold. It all seems so reasonable and so scientific, but the truth is that these studies don’t mean squat. And the researchers who do them know it, or at least should know it. The fact that they do know is evident in the weasel words they use in describing their findings. You’ll read that these data ‘suggest’ or that they ‘imply’ or that this ‘may cause’ that. The non-technically trained public, however, read these to say that vitamin C prevents the common cold. And usually the media helps to sway opinion by slanting the story in the same direction.

But, you may ask, why aren’t these studies sound? If the one group with the greater blood levels of vitamin C had significantly fewer colds, why is it such a stretch to say that vitamin C prevents colds?
I can explain by way of a game I used to play with myself as a child. I’ve never been one to sleep much even when I was a kid. I always stayed up late and I always woke up early. My brain never seemed to slow down. I was always ruminating on something. My way of trying to get to sleep was to try to think of everything that could be thought of. My mind would race, and I would think of my brothers sleeping in the room with me, their beds, my bed, the closet, the tree outside, my dad’s car, the rug on the floor, the moon, and on and on and on. As I thought faster and faster, continuing to compile things that could be thought of, I would finally hit a quitting point. Then I would try to figure if there was anything I hadn’t thought of. Of course, immediately I would think of something. I hadn’t thought of the pigs on my grandfather’s farm. Or I hadn’t thought of the fire hydrant out front. Or my father’s shoes. Or whatever. Then I would start the game again, this time, of course, starting with the pigs on my grandfather’s farm and going from there. I would always fall asleep before I had ever thought of everything there was to think of.

Researchers doing observational studies have much the same problem. They try to think of all the differences between two large populations of subjects so that they can statistically negate them so that only the observation in question – the vitamin C level in the example above – is different between the groups. Problem is they can never possibly think of all the differences between the groups. As a consequence, they never have a perfect study with exactly the same number, sex, age, lifestyle, etc. on both sides with the only difference being the study parameter. And so they don’t really ever prove anything. In fact, we would all probably be a lot better off if all the researchers doing observational studies had followed my lead and fallen asleep mid study.

But I’m being too harsh. These studies do have some value. Their value is in generating hypotheses.
The observational study demonstrates a correlation. In our example above, the correlation is that higher vitamin C levels correlate (in this particular study) with lower rates of colds. So, from this data, we could hypothesize that vitamin C prevents the common cold. But at this stage that would be just an hypothesis – not a fact.

Once we have the hypothesis, we can then do a randomize, placebo-controlled trial. We can recruit subjects, randomize them into two groups that are as equal as possible, especially as vitamin C levels are concerned. Then we give one group of subjects vitamin C and the other a placebo and watch them for a year. At the end of the year (or whatever the study period is), we break the codes, see who is on vitamin C and who is on placebo. We already know how many got colds, so now we compare that to vitamin C intake. We may find that those who took the vitamin C got significantly fewer colds, so we can say that our study demonstrates that vitamin C prevents the common cold. If this same study is repeated a number of times with the same outcome, then it can be said to be proven that vitamin C prevents colds. (This study is, of course, hypothetical.)

But these studies are randomized trials, not observational studies. Observational studies only show correlation, not causation, a fact that everyone doing research and reading about research should have tattooed on their foreheads.

CORRELATION IS NOT CAUSATION
More often than not observational studies are chock full of all kinds of technical-looking graphs, charts and tables. Many even have complicated equations. And long statistical analyses of the data derived. They are like zombies, however. They give the appearance of scientific life, but they are really scientifically dead. Irrespective of how many scientific baubles are strewn through them, they are nothing but observational studies, worthwhile only as generators of hypotheses. They demonstrate only correlation, not causation.

If you want to bear with me, I’ll show you a bizarre observational study that was actually performed that demonstrates everything you need to know about observational studies.

The study was published in 2003 in the prestigious American Journal of Epidemiology. The title of the study is Shaving, Coronary Heart Disease, and Stroke. (Click here for free full text) This study purports to show that the frequency of shaving correlates with risk for developing heart disease, with those men shaving less having a greater risk.

Here’s the finding that initiated this study.
A case-control study comparing the frequency of shaving in 21 men under 43 years of age who had suffered a myocardial infarction and 21 controls found that nine of the cases but none of the controls shaved only every 2 or 3 days.
Someone noticed that about half of the men in a small group of subjects who had a heart attack shaved once every two or three days. Another group of men of similar age who hadn’t had a heart attack were designated as controls. Upon questioning it was discovered that all of the men in the control group shaved every day. Thus the first hypothesis was born: Infrequent shaving correlates with heart attack.

The researchers had access to a large population of subjects from another ongoing study called the Caerphilly Study. Researchers recruited 2,513 men aged 45-59 from this study and gave them comprehensive medical workups including extensive laboratory testing.
Men were asked about their frequency of shaving by a medical interviewer during phase I. Responses were classified into categories ranging from twice daily to once daily, every other day, or less frequently. The 34 men with beards were not classified. These categories were dichotomized into once or twice per day and less frequently.
The men in the study were followed for the next 20 years with follow-up exams periodically to monitor for history of chest pain, heart attack and/or stroke.
Of the 521 men who shaved less frequently than daily, 45.1 percent died during the follow-up period, as compared with 31.3 percent of men who shaved at least daily.
When the data were further refined it was determined that
The age-adjusted hazard ratios demonstrate increased risks of all-cause, cardiovascular disease, and non-cardiovascular-disease mortality and all stroke events among men who shaved less frequently.
So there you have it. Proof that shaving daily prevents heart disease. Or is it?

The researchers doing this study aren’t so stupid that they really think that the act of shaving itself has anything to do with a man’s risk for developing heart disease. In fact, they went to great lengths to show that shaving was merely a marker for other things going on that may well have something to do with risk for developing heart disease or increased all-cause mortality.
The one fifth (n = 521, 21.4%) of men who shaved less frequently than daily were shorter, were less likely to be married, had a lower frequency of orgasm, and were more likely to smoke, to have angina, and to work in manual occupations than other men.
And these are just the differences the researchers found. Had they looked harder, I’m sure they would have found more, just like I did when I played my ‘think of everything that can be thought about’ game with myself as a kid.

But if these researchers had really believed that the data showed that the lack of frequent shaving itself may have been the driving force behind the development of heart disease, they may have designed a randomized clinical trial to show causality. They could have recruited men without heart disease, randomized them into two groups, instructed the men in one group to shave daily and the men in the other to shave every third day. Then after 20 years the researchers could tell whether or not shaving protects against heart disease.

But the idea that shaving itself has anything to do with heart disease is so ludicrous that no one would ever do such a study. We can all see that. It’s a ridiculous idea. It should be obvious that the shaving or lack thereof has nothing to do with heart disease or early death; the lack of shaving is merely a marker for all the other conditions that are risk factors for heart disease, i.e., small stature, unmarried, smoking, lower socioeconomic class, etc. It’s all so easy to see.

But let’s just suppose that we take this same study and substitute the term ‘elevated cholesterol’ for ‘infrequent shaving.’ Now what do we see? Let’s change one of the quotes from above to reflect this change. What then?
Of the 521 men who had elevated cholesterol, 45.1 percent died during the follow-up period, as compared with 31.3 percent of men who had low or normal cholesterol.
We nod our heads sagely. Suddenly we have a study that seems to make sense. But – and this is important – it doesn’t make any more sense than the shaving study. Both are observational studies. We are programmed to think cholesterol is bad and causes heart disease, so this second study appears reasonable to us. It triggers our confirmation bias. We don’t believe for a second that shaving has anything to do with heart disease, so we can easily dismiss those findings. But we are more than ready to believe that the elevated cholesterol caused those men who had it to have heart attacks. But the reality is that both studies are exactly the same – and neither proves anything.

If you’re interested in a longer, more in-depth article on observational studies, take a look at Gary Taubes long piece in the New York Times a few years ago. I’ve tried to take a little different slant than he did so that my post and his article would cover all the bases.

Cartoon above from: Smith, G. D. et al. Int. J. Epidemiol. 2001 30:1-11
==================================================================
Read the complete article here.

Monday, March 4, 2013

Current medical system is leading cause of death in US?


Death by Medicine


By Gary Null, PhD; Carolyn Dean MD, ND; Martin Feldman, MD; Debora Rasio, MD; and Dorothy Smith, PhD
Something is wrong when regulatory agencies pretend that vitamins and nutritional supplements are dangerous, yet ignore published statistics showing that government-sanctioned medicine is the real hazard.

Until recently, Life Extension could cite only isolated statistics to make its case about the dangers of conventional medicine. No one had ever analyzed and compiled all of the published literature dealing with injuries and deaths caused by government-protected medicine.

A group of researchers meticulously reviewed the statistical evidence and their findings are absolutely shocking.1-4 These researchers have authored the following article titled “Death by Medicine” that presents compelling evidence that today’s health care system frequently causes more harm than good.

This fully referenced report shows the number of people having in-hospital, adverse reactions to prescribed drugs to be 2.2 million annually. The number of unnecessary antibiotics prescribed for viral infections is 20 million per year. The number of unnecessary medical and surgical procedures performed is 7.5 million per year. The number of people exposed to unnecessary hospitalization is 8.9 million per year.

The most stunning statistic, however, is that the total number of deaths caused by conventional medicine is nearly 800,000 per year. It is now evident that the American medical system is the leading cause of death and injury in the US. By contrast, the number of deaths attributable to heart disease in 2001 was 699,697, while the number of deaths attributable to cancer was 553,251.5
Life Extension has decided to publish this article in its entirety to call attention to the failure of the American medical system. By exposing these gruesome statistics in painstaking detail, we provide a basis for competent and compassionate medical professionals to recognize the inadequacies of today’s system and at least attempt to institute meaningful reforms.

Natural medicine is under siege, as pharmaceutical company lobbyists urge lawmakers to deprive Americans of the benefits of dietary supplements and bioidentical hormones. Drug-company front groups have launched slanderous media campaigns to discredit the value of healthy lifestyles. The FDA continues to interfere with those who offer natural products that compete with prescription drugs.

These attacks against natural medicine obscure a lethal problem that until now was buried in thousands of pages of scientific text. In response to these baseless challenges to natural medicine, the Nutrition Institute of America commissioned an independent review of the quality of “government-approved” medicine. The startling findings from this meticulous study indicate that conventional medicine is the leading cause of death in the United States.

The Nutrition Institute of America is a nonprofit organization that has sponsored independent research for the past 30 years. To support its bold claim that conventional medicine is America’s number-one killer, the Institute mandated that every “count” in this “indictment” of US medicine be validated by published, peer-reviewed scientific studies.

What you are about to read is a stunning compilation of facts that documents that those who seek to abolish consumer access to natural therapies are misleading the public. Nearly 800,000 Americans die each year at the hands of government-sanctioned medicine, while the FDA and other government agencies pretend to protect the public by harassing those who offer safe alternatives.

A definitive review of medical peer-reviewed journals and government health statistics shows that American medicine frequently causes more harm than good.

Each year approximately 2.2 million US hospital patients experience adverse drug reactions (ADRs) to prescribed medications.6 In 1995, Dr. Richard Besser of the federal Centers for Disease Control and Prevention (CDC) estimated the number of unnecessary antibiotics prescribed annually for viral infections to be 20 million; in 2003, Dr. Besser spoke in terms of tens of millions of unnecessary antibiotics prescribed annually.7,8 Approximately 7.5 million unnecessary medical and surgical procedures are performed annually in the US,9,10 while approximately 8.9 million Americans are hospitalized unnecessarily.1-4

Table 1: Estimated Annual Mortality and Economic Cost of Medical Intervention
ConditionDeathsCostAuthor
Adverse Drug Reactions 106,000$12 billionLazarou6, Suh11
Medical error 98,000$2 billionIOM12,13
Bedsores 115,000$55 billionXakellis14, Barczak15
Infection 88,000$5 billionWeinstein16, MMWR17
Malnutrition 108,800-----------Nurses Coalition18
Outpatients 199,000$77 billionStarfield19,20, Weingart21
Unnecessary Procedures 37,136$122 billionHCUP22
Surgery-Related 32,000$9 billionAHRQ23
Total783,936$282 billion

As shown in Table 1, the estimated total number of iatrogenic deaths—that is, deaths induced inadvertently by a physician or surgeon or by medical treatment or diagnostic procedures—in the US annually is 783,936. It is evident that the American medical system is itself the leading cause of death and injury in the US. By comparison, approximately 699,697 Americans died of heart disease in 2001, while 553,251 died of cancer.

Using Dr. Lucian L. Leape’s 1997 medical and drug error rate of 3 million24 multiplied by the 14% fatality rate he used in 199425 produces an annual death rate of 420,000 for drug errors and medical errors combined. Using this number instead of Lazarou’s 106,000 drug errors and the Institute of Medicine’s (IOM) estimated 98,000 annual medical errors would add another 216,000 deaths, for a total of 999,936 deaths annually, as shown in Table 2.

Table 2: Estimated Annual Mortality and Economic Cost of Medical Intervention
ConditionDeathsCostAuthor
ADR/med error 420,000$200 billionLeape24
Bedsores 115,000$55 billionXakellis14, Barczak15
Infection 88,000$5 billionWeinstein16, MMWR17
Malnutrition 108,800-----------Nurses Coalition18
Outpatients 199,000$77 billionStarfield19,20, Weingart21
Unnecessary Procedures 37,136$122 billionHCUP22
Surgery-Related 32,000$9 billionAHRQ23
Total999,936

The enumeration of unnecessary medical events is very important in our analysis. Any invasive, unnecessary medical procedure must be considered as part of the larger iatrogenic picture.

Unfortunately, cause and effect go unmonitored. The figures on unnecessary events represent people who are thrust into a dangerous health care system. Each of these 16.4 million lives is being affected in ways that could have fatal consequences. Simply entering a hospital could result in the following:
  • In 16.4 million people, a 2.1% chance (affecting 186,000) of a serious adverse drug reaction6
  • In 16.4 million people, a 5-6% chance (affecting 489,500) of acquiring a nosocomial infection16
  • In 16.4 million people, a 4-36% chance (affecting 1.78 million) of having an iatrogenic injury (medical error or adverse drug reactions)25
These statistics represent a one-year time span. Working with the most conservative figures from our statistics, we project the following 10-year death rates.

Table 3: Estimated 10-Year Death Rates from Medical Intervention
Condition
10-Year Deaths
Author
Adverse Drug Reaction1.06 million Lazarou6
Medical error0.98 millionIOM12,13
Bedsores1.15 millionXakellis14, Barczak15
Nosocomial Infection0.88 millionWeinstein16, MMWR17
Malnutrition1.09 millionNurses Coalition18
Outpatients1.99 millionStarfield19,20, Weingart21
Unnecessary Procedures371,360HCUP22
Surgery-related 320,000AHRQ23
Total7,841,360

Our estimated 10-year total of 7.8 million iatrogenic deaths is more than all the casualties from all the wars fought by the US throughout its entire history.

Our projected figures for unnecessary medical events occurring over a 10-year period also are dramatic.

These figures show that an estimated 164 million people—more than half of the total US population—receive unneeded medical treatment over the course of a decade.

Table 4: Estimated 10-Year Unnecessary Medical Events
Unnecessary Events10-year NumberIatrogenic Events
Hospitalization89 million1-417 million
Procedures 75 million2215 million
Total164 million

Introduction

Never before have complete statistics on the multiple causes of iatrogenesis been combined in one article. Medical science amasses tens of thousands of papers annually, each representing a tiny fragment of the whole picture. To look at only one piece and try to understand the benefits and risks is like standing an inch away from an elephant and trying to describe everything about it. You have to step back to see the big picture, as we have done here. Each specialty, each division of medicine keeps its own records and data on morbidity and mortality. We have now completed the painstaking work of reviewing thousands of studies and putting pieces of the puzzle together.

Is American Medicine Working?

US health care spending reached $1.6 trillion in 2003, representing 14% of the nation’s gross national product.26 Considering this enormous expenditure, we should have the best medicine in the world. We should be preventing and reversing disease, and doing minimal harm. Careful and objective review, however, shows we are doing the opposite. Because of the extraordinarily narrow, technologically driven context in which contemporary medicine examines the human condition, we are completely missing the larger picture.
Medicine is not taking into consideration the following critically important aspects of a healthy human organism:
  • stress and how it adversely affects the immune system and life processes
  • insufficient exercise
  • excessive calorie intake
  • highly processed and denatured foods grown in denatured and chemically damaged soil
  • exposure to tens of thousands of environmental toxins.
Instead of minimizing these disease-causing factors, we cause more illness through medical technology, diagnostic testing, overuse of medical and surgical procedures, and overuse of pharmaceutical drugs. The huge disservice of this therapeutic strategy is the result of little effort or money being spent on preventing disease.
.
.
.
.
===================================================================
Read the complete article here.